Home

Conference

Study results

Register for Conference

Monitoring the performance of vaccination programmes in the European Union

28 September 2023 at TownHall Europe in Brussels

A one-day hybrid conference with competent national authorities representing all EU Member States in order to present and discuss the draft study results.

Conference agenda

09:00

Welcome and onsite/online registration

Attendees arriving in person are welcomed with coffee and tea and will receive name tags and further instructions.


Online participants are welcomed in an online space and will be instructed on how to use the online system.

09:30

Opening of the event

The opening note will be held by an inspirational speaker on the topic of vaccination, emphasizing the relevance of this meeting. Potentially a high-level speaker from DG SANTE.

09:35

Introduction to the study by HaDEA

An opening note by Martine Ingvorsen, European Commission, DG Santé (remote)

09:40

Commission action to improve the uptake of vaccination

The study team presents selected country and pan-European findings from the mapping of existing methodologies.

09:50

Existing methodologies and challenges in the performance monitoring of vaccination programmes in EU Member States and regions

Presented by the Contractor

10:40

Coffee break

11:00

Monitoring practices from three EU Member States - panel presentations and discussions

Panel presentations and discussions by experts from the Member States

12:00

Lunch

According to key indicators and themes (around recommendations). 


Themes for breakout rooms are conceptual and will be reviewed in the course of the study, based on findings in the mapping and the draft recommendations and pre-conference feedback on draft recommendations.

13:15

Draft set of recommendations to improve the performance monitoring of vaccination programmes in EU Member States and regions

With focus on different challenges and case studies on good practices and their transferability to other settings

14:00

Break (move to breakout rooms)

According to key indicators and themes (around recommendations)

Themes for breakout rooms are conceptual and will be reviewed in the course of the study based on findings in the mapping and the draft recommendations and pre-conference feedback on draft recommendations.

14:10

Three breakout sessions (part 1) which focus on country context and transferability of the different aspects of the draft recommendations

  1. Monitoring strategies
  2. Electronic vaccination registries
  3. Acceptability monitoring

To improve the performance monitoring of vaccination programmes in EU Member States and regions - Presented by the Contractor

15:10

Coffee break

Drinks and snacks will be provided.

15:30

Three breakout sessions (part 2) which focus on country context and transferability of the different aspects of the draft recommendations

  1. Monitoring strategies
  2. Electronic vaccination registries
  3. Acceptability monitoring

With focus on country context and transferability of the different aspects of the draft recommendations

16:30

Break (move to main hall)

Drinks and snacks will be provided.

16:40

Closing session: Lessons learnt and the way forward

Presented by the moderators of the 6 breakout sessions and the Contractor

17:00

Informal networking event

Drinks and snacks will be provided.

18:00

End

Drinks and snacks will be provided.

Speakers and moderators

Prof Maarten J Postma

Function title

Dr Jan Kyncl (MD, PhD)

Function title

Martine Ingvorsen

Function title

Dr John Paget (PhD)

Function title

Agnès Mathieu-Mendes

Function title

Anna Gumbau

Function title

Elena Gabriel

Function title

Ivan Miškulin

Function title

Jeanne-Marie Hament

Function title

Full name

Function title

Venue

TownHall Europe

Square de Meeûs 5-6

1000 Brussels, Belgium

www.townhalleurope.eu


Plan your trip



Conference secretariat

For any question related to the conference, please contact us at:


events@schuttelaar-partners.com

Frequently asked questions

Who should attend this conference? 

Regional, national and European experts involved in vaccination programmes and policies in any and all Member States are invited to this conference.

Why should I attend this event? 

Beside discussing the preliminary outcomes of the study on methods for the performance monitoring of vaccination programmes across Europe, this event will provide an excellent opportunity to exchange knowledge and experiences with colleagues from other EU Member States and to discuss challenges related to the implementation of monitoring systems.

I cannot attend in person; Can I follow online? 

Although in-person attendance at the conference is preferable, online participation will be possible. Online participation will limit access to the afternoon breakout sessions: only one breakout session per round will be accessible through an online platform.

Will my travel expenses be reimbursed? 

Reimbursement is available for a maximum of two representatives of health authorities per Member State; Those eligible for reimbursement will be notified and agreed in advance. Reimbursement will be made according to the Commission Delegated Regulation (EU) 2016/1611 of 7 July 2016 and extend to one night of hotel accommodation (maximum amount of € 148 (VAT included) and return flight or train tickets to Brussels (economy class)). All reimbursements are made directly by the conference organisers upon electronic receipt of travel and hotel invoices within 6 weeks after the conference. Please contact us if you have questions about reimbursement or your eligibility for reimbursement.

What will be the outputs of the conference?

There will be two key outputs from the conference:

  1. A conference report to summarize the conference findings. This will be published on this website after the conference. 
  2. A final set of recommendations adjusted based on the discussions and input received at the conference. These recommendations will be translated into all EU languages and shared with conference participants in early 2024.

Who do I contact with questions about the conference? 

If your question is related to reimbursement, logistics, the agenda or accessibility requirements please contact the secretariat events@schuttelaar-partners.com.


If your enquiry is around technical content or to recommend yourself or another attendee from a Member State, please email the study team at vaccinationprogrammeseustudy@technopolis-group.com.

Reimbursement of travel expenses

For a maximum of two representatives of health authorities per Member State one night of hotel accommodation and flight or train tickets (economy class) will be reimbursed. According to the Commission Delegated Regulation (EU) 2016/1611 of 7 July 2016 the hotel costs will be covered up to an amount of € 148 (VAT included). All reimbursements are made directly by the conference organisers upon electronic receipt of travel and hotel invoices within 6 weeks after the conference.

Study team

To find out more or to participate in the study please contact us at: 

vaccinationprogrammeseustudy@technopolis-group.com.

This online portal has been funded by the European Union under the EU4Health Programme, service contract HADEA/2022/OP/0002. The information and views set out on this portal are those of the authors and do not necessarily reflect the official opinion of the European Commission.

©HaDEA and the Union, 2023. Certain parts are licensed under conditions to the EU. - Data Protection Notice

Prof Maarten J Postma

Function title

Chair of Global Health Economics at University Medical Center Groningen (UMCG) and Faculty of Economics & Business and Director of Research Institute SHARE, University of Groningen, Netherlands; Professor of Pharmacoeconomics at Airlangga University, Surabaya, Indonesia and Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia; Expert consultant for WHO and Member of WHO’s Strategic Advisory Group of Experts on Immunization (SAGE).

Dr Jan Kyncl (MD, PhD)

Function title

National Institute of Public Health, Prague, Czech Republic; Member of Global Influenza Initiative Steering Committee and European Influenza Surveillance Network.

Martine Ingvorsen

Function title

Policy Officer, DG SANTE, European Commission

Dr John Paget (PhD)

Function title

Senior Scientist - Infectious Diseases
Netherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands

Agnès Mathieu-Mendes 

Function title

Head of Unit, Health and Digital Executive Agency (HaDEA) 


Agnès Mathieu-Mendes is Head of Unit responsible for the implementation of the EU programme on health and food in the health and digital executive agency HDEA created by the European Commission. 


She has also been working for many years in the pharmaceutical field in the European Commission in the Directorate General SANTE and the Directorate General for enterprise and industry. 


She is an industrial pharmacist by training and has a diploma in pharmaceutical engineering and industrial technology.

Anna Gumbau

Function title

Moderator

Elena Gabriel

Function title

Nursing Officer, Ministry of Health, Cyprus

Ivan Miškulin

Function title

Professor, Head of the Department of Public Health, Faculty of Medicine, Osijek, Croatia

Jeanne-Marie Hament

Function title

RIVM Netherlands